Home / NYT / The F.D.A. suspends use of a Glaxo antibody drug in the U.S. as an Omicron subvariant spreads.

The F.D.A. suspends use of a Glaxo antibody drug in the U.S. as an Omicron subvariant spreads.

Technology


By BY ADEEL HASSAN from NYT Health https://ift.tt/cHEVJZ2
The F.D.A. suspends use of a Glaxo antibody drug in the U.S. as an Omicron subvariant spreads. The F.D.A. suspends use of a Glaxo antibody drug in the U.S. as an Omicron subvariant spreads. Reviewed by Virual stuff on April 05, 2022 Rating: 5

Ad Home

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.